ChangeBridge: EPO Bulletin - Pharma (A61K)

EPO Patent Publication: Novel Composition for Hair and Scalp Condition

The European Patent Office has published a new patent application, EP4511051A1, detailing a novel composition for improving hair and scalp condition. The publication includes details on the applicants, inventors, and International Patent Classifications related to the composition.

Patent EP4525868A1: Deuterated Domperidone for Gastroparesis

The European Patent Office has published patent application EP4525868A1, filed by CinDome Pharma, Inc., for deuterated domperidone intended for treating gastroparesis. The publication date is March 18, 2026.

EPO Patent Publication EP4526313A1: Trehalose-based Surfactants

The European Patent Office (EPO) published patent application EP4526313A1 on March 18, 2026, concerning trehalose-based surfactants developed by MedXCell SA. This publication details new chemical compounds and their potential applications in pharmaceutical formulations.

EPO Patent EP4518972A2 on Vectorized Anti-Complement Antibodies

The European Patent Office has published patent application EP4518972A2 filed by RegenxBio Inc. The patent covers vectorized anti-complement antibodies and related administration methods. The publication date is March 18, 2026.

Myostatin Inhibitor for Spinal Muscular Atrophy Treatment Patent

The European Patent Office has published a patent application (EP4518970A2) for Scholar Rock, Inc. concerning the use of a myostatin inhibitor for treating spinal muscular atrophy. The patent details specific chemical compounds and their therapeutic applications.